About Incyte Corporation (INCY)
Incyte Corporation is a Biotechnology company operating in the Healthcare sector.
INCY trades on the US stock exchanges (NYSE/NASDAQ) and is classified as a large-cap stock .
Key Statistics
- Current Price
- $120.39
- Market Cap
- $24.54B
- 52-Week High
- $132.60
- 52-Week Low
- $89.25
- Sector
- Healthcare
- Industry
- Biotechnology
$1,000 Invested in Incyte Corporation (INCY)
How much would $1,000 invested in INCY be worth today?
What would $1,000 invested in INCY 1 year ago be worth today?
A $1,000 investment in Incyte Corporation (INCY) in 2025 would be worth $1,300 as of November 2026, representing a +30.0% total return.
What would $1,000 invested in INCY 3 years ago be worth today?
A $1,000 investment in Incyte Corporation (INCY) in 2023 would be worth $2,218 as of November 2026, representing a +121.8% total return.
What would $1,000 invested in INCY 5 years ago be worth today?
A $1,000 investment in Incyte Corporation (INCY) in 2021 would be worth $1,804 as of November 2026, representing a +80.4% total return.
What would $1,000 invested in INCY 10 years ago be worth today?
A $1,000 investment in Incyte Corporation (INCY) in 2016 would be worth $1,372 as of November 2026, representing a +37.2% total return.
What would $1,000 invested in INCY at IPO be worth today?
A $1,000 investment in Incyte Corporation (INCY) at IPO would be worth $64,208 as of November 2026, representing a +6320.8% total return.
Monthly Returns Heatmap
Over the past 32+ years (395 months), Incyte Corporation (INCY) has averaged a monthly return of +2.63% with a median return of +0.71%. The stock had 206 positive months (52%) and 184 negative months (47%). The best month in INCY's history was February 2000 with a +151.1% return, while the worst was March 2000 at -68.3%. Historically, December tends to be the strongest month (averaging +9.1%), and March the weakest (-4.0%).
INCY's longest winning streak was 8 consecutive months of gains, while its longest losing streak was 8 consecutive months of losses. The best full year was 2000 with a cumulative return of +134.2%, and the worst was 2002 at -124.1%.
Annual Returns
Over 33 years of trading history, Incyte Corporation (INCY) has delivered an average annual return of +26.39% with a median return of +10.66%. The compound annual growth rate (CAGR) is +12.82%. The stock posted gains in 20 years (61%) and losses in 13 years (39%).
INCY's best year was 2013 with a +204.82% gain, while the worst was 2002 at -76.54%. The longest streak of consecutive positive years was 4, and the longest losing streak was 3 years. INCY achieved double-digit gains (10%+) in 18 years. It suffered double-digit losses in 9 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +21.89% | $98.77 | $120.39 |
| 2025 | +43.00% | $69.07 | $98.77 |
| 2024 | +10.00% | $62.79 | $69.07 |
| 2023 | -21.83% | $80.32 | $62.79 |
| 2022 | +9.43% | $73.40 | $80.32 |
| 2021 | -15.61% | $86.98 | $73.40 |
| 2020 | -0.39% | $87.32 | $86.98 |
| 2019 | +37.32% | $63.59 | $87.32 |
| 2018 | -32.86% | $94.71 | $63.59 |
| 2017 | -5.55% | $100.27 | $94.71 |
| 2016 | -7.54% | $108.45 | $100.27 |
| 2015 | +48.34% | $73.11 | $108.45 |
| 2014 | +44.40% | $50.63 | $73.11 |
| 2013 | +204.82% | $16.61 | $50.63 |
| 2012 | +10.66% | $15.01 | $16.61 |
| 2011 | -9.36% | $16.56 | $15.01 |
| 2010 | +81.78% | $9.11 | $16.56 |
| 2009 | +140.37% | $3.79 | $9.11 |
| 2008 | -62.29% | $10.05 | $3.79 |
| 2007 | +72.09% | $5.84 | $10.05 |
| 2006 | +9.36% | $5.34 | $5.84 |
| 2005 | -46.55% | $9.99 | $5.34 |
| 2004 | +46.05% | $6.84 | $9.99 |
| 2003 | +50.00% | $4.56 | $6.84 |
| 2002 | -76.54% | $19.44 | $4.56 |
| 2001 | -21.85% | $24.88 | $19.44 |
| 2000 | -17.08% | $30.00 | $24.88 |
| 1999 | +60.54% | $18.69 | $30.00 |
| 1998 | -16.94% | $22.50 | $18.69 |
| 1997 | +74.76% | $12.88 | $22.50 |
| 1996 | +106.00% | $6.25 | $12.88 |
| 1995 | +80.18% | $3.47 | $6.25 |
| 1994 | +54.17% | $2.25 | $3.47 |
Frequently Asked Questions: INCY
What sector is INCY in? ▼
INCY operates in the Healthcare sector, specifically in the Biotechnology industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has INCY performed historically? ▼
Over 33 years of trading history, INCY has posted gains in 20 years (61% of the time). The best year was 2013 with a +204.8% return. Past performance does not guarantee future results.
How can I invest in INCY? ▼
You can invest in INCY through any brokerage account that offers access to US stock exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold INCY.
Last updated: 11/1/2026